News

These tests promise to show how much cellular ‘wear and tear’ your body has undergone, and how that corresponds with your age ...
Maggie Lawson has been cast as a series regular in “Boston Blue,” CBS‘ upcoming spinoff of “Blue Bloods.”. She will play Boston Police Department superintendent Sarah Silver, who is ...
Blood test identifies biological markers for teen depression and severity. Your friend's email. Your email. I would like to subscribe to Science X Newsletter. Learn more. Your name. Note.
SAN FRANCISCO — Patients with asthma who did not persist with biologic treatment had more exacerbations and used more oral corticosteroids, according to an abstract presented at the American ...
The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...
Verdin is 68, but after "optimizing" his health for the past decade, by making diet and lifestyle tweaks, he said that his "biological age" is much younger, based on various epigenetic blood tests.
CBS aired the final episode of “Blue Bloods” on Dec. 13. The hit series starred Wahlberg, Tom Selleck, Will Estes, and Bridget Moynahan. After the finale aired, Wahlberg penned an emotional ...
Donnie Wahlberg did everything he could to keep "Blue Bloods" alive before moving on to "Boston Blue." The actor knew he wanted to keep the storyline going before signing on to the spinoff series.
Biological age is based on biomarkers of aging such as lung function, blood pressure and cholesterol. Skip to main content. Your source for the latest research news. Follow: ...
Finding such biologics, though, could be difficult. So, Vivtex developed a microplate-based, robotic drug-testing system that mimics the environment of the gastrointestinal tract.
The National Carriers Conference Committee (NCCC) on April 25 announced that members of the International Brotherhood of Boilermakers (IBB) have voted to ratify a national collective bargaining ...
Overall, 16 (18.4%) patients switched to other biologics because of an early loss of therapeutic efficacy. Obesity (BMI ≥ 25) was the only clinical factor independently associated with biologic ...